Evidence map›Paper›PMID 32245975›Full record

ArticleCell death & disease2020

Cross organelle stress response disruption promotes gentamicin-induced proteotoxicity.

Chinaemere Igwebuike, Julia Yaglom, Leah Huiting, Hui Feng, Joshua D Campbell, Zhiyong Wang, Andrea Havasi, David Pimentel, Michael Y Sherman, Steven C Borkan

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 33 citations in OpenAlex.

  1. An AOP-guidedNAM journal · 2026
    Article
  2. Molecular mechanisms attributed to colistin renal proximal tubular epithelial cytotoxicity.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2025
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Chinaemere IgwebuikeBoston Medical Center, Department of Medicine, Renal Section, Boston, MA, USA.
Julia YaglomBoston University School of Medicine, Department of Biochemistry, Boston, MA, USA.
Leah HuitingBoston University School of Medicine, Department of Pharmacology and Experimental Therapeutics, Boston, MA, USA.
Hui FengBoston University School of Medicine, Department of Pharmacology and Experimental Therapeutics, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1318-821X
Joshua D CampbellBoston University School of Medicine, Department of Computational Biomedicine, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0780-8662
Zhiyong WangBoston Medical Center, Department of Medicine, Renal Section, Boston, MA, USA.
Andrea HavasiBoston Medical Center, Department of Medicine, Renal Section, Boston, MA, USA.
David PimentelBoston University School of Medicine, Department of Cardiology, Boston, MA, USA.
Michael Y ShermanAriel University, Department of Molecular Biology, Ariel, West Bank, Israel.
Steven C BorkanBoston Medical Center, Department of Medicine, Renal Section, Boston, MA, USA. sborkan@bu.edu.
Boston University · USBoston Medical Center · US

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
CYTOPROTECTIVE ROLE OF HSP72 IN RENAL CELL INJURYR01DK053387 · NIDDK · BOSTON MEDICAL CENTER · PI BORKAN, STEVEN C. · 1999 to 2016
$5.1M
Nucleophosmin Centered Diagnostics and Treatment of Ischemic Acute Kidney InjuryR01DK118267 · NIDDK · BOSTON MEDICAL CENTER · PI STEVEN C. BORKAN · 2019 to 2026
$2.8M
The Role of DLST in LeukemogenesisR01CA215059 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FENG, HUI · 2018 to 2022
$2.0M
Prevention and Treatment of Antibiotic-Induced Acute Kidney Injury Using an Unbiased Gene-Screen StrategyF30DK117612 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI IGWEBUIKE, CHINAEMERE · 2019 to 2021
$152k
NCATS NIH HHS UL1 TR001430NCI NIH HHS R01 CA215059NIDDK NIH HHS F30 DK117612NIDDK NIH HHS R01 DK053387NIDDK NIH HHS R01 DK118267
6 · The paper itself

Abstract

Gentamicin is a nephrotoxic antibiotic that causes acute kidney injury (AKI) primarily by targeting the proximal tubule epithelial cell. The development of an effective therapy for gentamicin-induced renal cell injury is limited by incomplete mechanistic insight. To address this challenge, we propose that RNAi signal pathway screening could identify a unifying mechanism of gentamicin-induced cell injury and suggest a therapeutic strategy to ameliorate it. Computational analysis of RNAi signal screens in gentamicin-exposed human proximal tubule cells suggested the cross-organelle stress response (CORE), the unfolded protein response (UPR), and cell chaperones as key targets of gentamicin-induced injury. To test this hypothesis, we assessed the effect of gentamicin on the CORE, UPR, and cell chaperone function, and tested the therapeutic efficacy of enhancing cell chaperone content. Early gentamicin exposure disrupted the CORE, evidenced by a rise in the ATP:ADP ratio, mitochondrial-specific H

Indexed as

Acute Kidney InjuryAnti-Bacterial AgentsEndoplasmic Reticulum StressGentamicinsHumansAnti-Bacterial AgentsGentamicins

Identifiers

PMID32245975
PMCPMC7125232
OpenAlexW3014452388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.